The thrombophilic factor V Leiden mutation (resistance to activated protein C) and estrogen replacement therapy as risk factors for atherothrombotic cardiovascular disease in 423 hyperlipidemic women.

被引：0
|
作者：
Glueck, CJ [1 ]
Wang, P [1 ]
Fontaine, RN [1 ]
Tracy, T [1 ]
Sieve-Smith, L [1 ]
Lang, JE [1 ]
机构：
[1] Jewish Hosp Cincinnati, Ctr Cholesterol, Cincinnati, OH 45229 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1999年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：246A / 246A
页数：1
相关论文
共 50 条
  • [1] The thrombophilic Factor V Leiden mutation (resistance to activated protein C) and estrogen replacement therapy as risk factors for atherothrombotic cardiovascular disease in 423 hyperlipidemic women
    Glueck, CJ
    Wang, P
    Fontaine, RN
    Tracy, T
    Sieve-Smith, L
    Lang, JE
    CIRCULATION, 1999, 100 (18) : 331 - 331
  • [2] The thrombophilic factor V Leiden mutation (resistance to activated protein C) is not a significant risk factor for atherothrombotic vascular disease in 396 hyperlipidemic men.
    Glueck, CJ
    Wang, P
    Fontaine, RN
    Tracy, T
    Sieve-Smith, L
    Lang, JE
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (07) : 261A - 261A
  • [3] The Factor V Leiden mutation and estrogen therapy: Risk factors for atherothrombotic cardiovascular disease.
    Glueck, CJ
    Wang, P
    Tracy, T
    Sieve-Smith, L
    Lang, J
    FASEB JOURNAL, 1999, 13 (04): : A513 - A513
  • [4] Estrogen replacement therapy and the Factor V Leiden mutation, interaction for atherothrombotic cardiovascular disease?.
    Glueck, CJ
    Wang, P
    Tracy, T
    Sieve-Smith, L
    Lang, J
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (04) : 190A - 190A
  • [5] Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the Factor V Leiden mutation (resistance to activated protein C)
    Glueck, CJ
    Wang, P
    Fontaine, RN
    Tracy, T
    Sieve-Smith, L
    Lang, JE
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (05): : 549 - 554
  • [6] Activated protein C resistance and factor V Leiden mutation are risk factors for cerebral sinus thrombosis
    Siegert, CEH
    Smelt, AHM
    deBruin, TWA
    STROKE, 1997, 28 (06) : 1291 - 1292
  • [7] Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism
    Rodeghiero, F
    Tosetto, A
    ANNALS OF INTERNAL MEDICINE, 1999, 130 (08) : 643 - +
  • [8] Factor V Leiden mutation and acquired activated protein C resistance in women with recurrent miscarriage
    Cohen, H
    Holmes, Z
    Atoyebi, W
    Pickering, W
    Regan, L
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2978 - P2978
  • [9] Interaction of estrogen replacement therapy with the thrombophilic 20210 G/A prothrombin gene mutation for atherothrombotic vascular disease: A cross-sectional study of 275 hyperlipidemic women
    Glueck, CJ
    Wang, P
    Fontaine, RN
    Sieve-Smith, L
    Lang, JE
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (03): : 360 - 365
  • [10] Activated protein C resistance and the factor V Leiden mutation in children with thrombosis
    Nuss, R
    Sifontes, M
    Hunger, SP
    Waters, J
    Jacobson, LJ
    MancoJohnson, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1261 - P1261
12345